Clinical Algorithm Transparency Law In Russia.

1. Introduction

Clinical Algorithm Transparency Law in Russia concerns the legal rules governing the use of artificial intelligence (AI), machine-learning systems, automated diagnostic software and clinical decision-support algorithms in medical treatment.

Clinical algorithms are increasingly used in Russian healthcare for:

Detecting cancer through medical imaging.

Identifying cardiovascular diseases.

Analysing laboratory reports.

Predicting disease progression.

Recommending medical treatment.

Assessing patient risks.

Supporting doctors in making clinical decisions.

Prioritising patients through automated triage systems.

The central legal question is whether a patient has the right to know when an algorithm influences their diagnosis, treatment or medical risk assessment.

An important distinction: Russia does not have a single comprehensive federal statute specifically establishing a general right to explanation of clinical AI algorithms. Instead, transparency obligations and patient protections arise from constitutional guarantees, medical legislation, personal-data legislation, medical-device regulation and experimental legal regimes.

Consequently, Russian clinical algorithm transparency law is a developing and fragmented regulatory framework.

2. Constitutional framework governing clinical algorithm transparency

The Russian Constitution provides the foundation for protecting patients against opaque or arbitrary clinical decision-making.

The following provisions are particularly important:

Constitutional provisionLegal significance
Article 21Protection of human dignity.
Article 23Right to privacy and protection of private life.
Article 24Protection against unlawful collection and disclosure of private information.
Article 29Freedom to seek and receive information.
Article 41Right to health protection and medical assistance.
Article 45State protection of individual rights.
Article 46Right to judicial protection.

Legal interpretation

If a hospital uses an AI algorithm to recommend cancer treatment, identify a neurological disorder or assess the probability of a patient's death, the resulting clinical process must respect the patient's constitutional rights.

For example, a hospital should not treat an algorithmic recommendation as an unquestionable decision when it affects the patient's health, dignity or access to appropriate medical treatment.

Articles 24, 29 and 41 are particularly relevant to arguments that patients should receive understandable information about medical decisions affecting them.

However, these constitutional provisions do not independently establish a specific technical right to inspect source code or obtain the mathematical details of a clinical algorithm.

3. Federal Law No. 323-FZ of 21 November 2011

Federal Law on the Fundamentals of Health Protection of Citizens in the Russian Federation

This is the principal legislation governing medical treatment, patients' rights and medical organisations in Russia.

Several provisions are particularly relevant to clinical algorithm transparency.

A. Article 19 – Patient rights

Article 19 recognises patients' rights to:

Receive medical assistance.

Obtain information about their health.

Protect medical confidentiality.

Choose a medical organisation and doctor in accordance with applicable law.

Refuse medical intervention.

Obtain compensation for harm caused to their health.

This provision creates an important foundation for transparency when an algorithm influences clinical care.

For example, where an algorithm identifies a patient as having a high cancer risk, the patient should be able to obtain information about the medical findings and diagnosis through the healthcare professional.

B. Article 20 – Informed voluntary consent

Article 20 is central to algorithm-assisted medicine.

It requires informed voluntary consent before medical intervention, based on accessible and sufficiently complete information about:

The objectives of medical assistance.

The methods of providing medical assistance.

Associated risks.

Available alternatives.

Possible consequences.

Expected results.

Ministry of Health+1

Consider a situation in which a hospital recommends surgery based on an AI-powered diagnostic system.

The doctor should explain the proposed intervention, its risks, alternatives and expected results. If the algorithm materially influences the recommendation, disclosing that involvement may be important to making the consent genuinely informed.

Nevertheless, Article 20 does not expressly require a separate AI disclosure document for every algorithm-assisted clinical decision.

C. Article 22 – Information about the patient's health

Article 22 provides patients with the right to receive accessible information about:

Medical examination results.

Diagnosed diseases.

Prognosis.

Medical treatment methods.

Associated risks.

Possible medical interventions.

Consequences and results of medical treatment.

It also provides for access to medical documentation.

This provision is especially important because algorithm-generated clinical findings may become part of the medical evidence supporting a diagnosis.

A patient can therefore seek access to relevant medical findings and documentation, although this does not automatically create a right to obtain proprietary source code or the complete internal architecture of the AI system.

D. Article 73 – Duties of medical professionals

Medical professionals must comply with their professional obligations, including maintaining medical confidentiality.

A doctor cannot simply avoid responsibility by claiming that an incorrect diagnosis was generated by artificial intelligence.

E. Article 79 – Duties of medical organisations

Medical organisations have obligations concerning medical documentation, patient information, medical confidentiality and the organisation of safe medical services.

These obligations are relevant when clinical algorithms are incorporated into hospital information systems.

Consultant Plus+1

4. Federal Law No. 152-FZ of 27 July 2006 – Personal Data Protection

The Federal Law on Personal Data is one of the most important legal instruments governing clinical algorithms.

AI-based clinical systems frequently process:

Patient medical histories.

Genetic information.

Laboratory results.

MRI and CT scans.

Biometric information.

Medication histories.

Personal identifiers.

Predictive health assessments.

A. Article 5 – Principles of personal-data processing

Personal-data processing must comply with principles of legality, fairness, purpose limitation, proportionality and accuracy.

This means that medical organisations cannot freely collect unlimited patient information simply because it might improve an algorithm's predictive performance.

B. Article 9 – Consent

Where consent is the legal basis for processing personal data, it must be freely given, specific, informed and conscious.

Other lawful grounds for processing may also apply under the legislation.

C. Article 10 – Special categories of personal data

Information concerning health belongs to specially protected categories of personal data.

Its processing is generally restricted, subject to statutory exceptions.

This is important when hospitals use patient records to train or improve clinical AI systems.

D. Article 16 – Automated decision-making

Key transparency provision

Article 16 establishes protections against decisions based exclusively on automated processing of personal data where those decisions produce legal consequences or otherwise affect the individual's rights and legitimate interests.

Where the statutory conditions for automated decision-making are met, the operator must:

Explain the procedure for making the automated decision.

Explain its possible legal consequences.

Provide an opportunity to object.

Explain how the individual can protect their rights.

Consider the objection within 30 days and communicate the outcome.

Consultant Plus+1

Example:

A hospital uses an automated algorithm to determine which patients qualify for a particular treatment programme.

If the algorithm independently excludes a patient, Article 16 may become relevant because the decision affects the patient's rights or legitimate interests.

However, there is an important legal distinction:

A clinical recommendation is not automatically a decision covered by Article 16. Its application depends on whether the decision is exclusively automated and has the required effect on the patient's rights or legitimate interests.

A doctor's meaningful clinical review may also change the legal analysis.

Furthermore, Article 16 does not establish a general right to receive the algorithm's source code, training dataset or complete mathematical model.

5. Federal Law No. 258-FZ of 31 July 2020 – Experimental Legal Regimes

Russia has developed experimental legal regimes for digital and technological innovation.

Federal Law No. 258-FZ provides the legal framework for regulatory experimentation involving innovative technologies.

Its importance for healthcare AI includes the possibility of testing new technological and organisational arrangements under specially approved experimental conditions.

Relevant areas include:

AI-assisted medical services.

Digital healthcare platforms.

Remote patient monitoring.

Automated medical assessments.

Innovative healthcare delivery models.

Article 36.2 of Federal Law No. 323-FZ also recognises specific possibilities for modifying certain telemedicine requirements for eligible private medical organisations participating in experimental regimes.

However, experimental permission does not mean that all patient-protection obligations disappear.

Medical confidentiality, applicable personal-data protections and relevant safety requirements remain important.

cis-legislation.com+1

6. Medical-device regulation and algorithmic safety

Clinical algorithms may qualify as medical software or medical devices depending on their intended medical purpose and functionality.

The relevant regulatory framework includes:

Federal Law No. 323-FZ.

Government Resolution No. 1416 of 27 December 2012, concerning registration of medical devices.

Applicable technical regulations and medical-device safety requirements.

Relevant Russian and international standards adopted for medical-device risk management.

For an AI-based medical device, important compliance issues include:

Algorithm validation: The manufacturer should establish that the system performs its intended medical function.

Risk management: Potential diagnostic errors and unsafe recommendations must be identified and managed.

Clinical performance: The system should be evaluated in conditions relevant to its intended use.

Software updates: Changes to algorithms must be controlled so that updates do not introduce unacceptable risks.

Post-market monitoring: Safety and performance problems should be identified after deployment.

For example, if a radiology algorithm repeatedly fails to identify early-stage lung cancer, the problem may involve inadequate validation, defective software, unsuitable training data or improper clinical implementation.

Medical-device risk management is therefore an important component of practical algorithm transparency.

medet.rsmu.press+1

7. Judicial precedents and case laws

An important research qualification is necessary: there is no established body of Russian reported judgments specifically deciding patients' rights to explanations of AI-generated clinical diagnoses. The following cases provide relevant legal principles by analogy.

Case 1. Constitutional Court of the Russian Federation – Judgment No. 1-P of 13 January 2020

Highly relevant precedent

Subject: Access to medical documentation and medical confidentiality.

The Constitutional Court considered the relationship between medical confidentiality, patients' rights and access to the medical records of deceased patients.

The dispute concerned whether the deceased patient's spouse and relatives could obtain access to medical documentation in circumstances where the patient had identified persons who could receive health information.

The Court found that the existing legal framework was constitutionally deficient because its uncertainty did not adequately determine the conditions and procedure for access to such medical records.

The Court emphasised the significance of:

Article 24 of the Constitution.

Article 19 of Federal Law No. 323-FZ.

Article 20 of Federal Law No. 323-FZ.

Article 22 of Federal Law No. 323-FZ.

Relevance to clinical algorithm transparency

The judgment establishes that medical confidentiality cannot be interpreted as a reason to deny an individual access to information that directly concerns their rights and legitimate interests.

Applied by analogy, a hospital should not automatically rely on the confidentiality of its AI system to deny a patient access to relevant medical information contained in their clinical records.

However, the judgment does not establish a right to access proprietary algorithm source code.

Consultant Plus+1

Case 2. Konovalova v. Russia – European Court of Human Rights, 9 October 2014

Application No. 37873/04

Subject: Patient autonomy, privacy and informed consent.

The applicant complained that medical students had been permitted to observe her childbirth without her explicit consent.

The European Court of Human Rights examined the adequacy of safeguards protecting the patient's private life.

The Court found a violation of Article 8 of the European Convention on Human Rights.

Legal principle

Medical institutions must provide adequate safeguards to protect patient privacy and autonomy.

Patients should not be subjected to medical-related activities involving third parties without appropriate legal safeguards.

Relevance to clinical algorithm transparency

Although the case did not concern artificial intelligence, its reasoning is relevant when a medical organisation introduces AI systems that involve external developers, data processors or third-party technology providers.

The case supports the importance of protecting patient autonomy, privacy and confidentiality when new technological participants become involved in medical treatment.

HUDOC+1

Jurisdictional qualification: This is a Strasbourg judgment concerning Russia, not a Russian domestic judgment. Its current enforceability and relevance must be assessed in light of Russia's withdrawal from the European Convention system in 2022.

Case 3. Constitutional Court of the Russian Federation – Judgment No. 31-P of 13 July 2022

Subject: Medical documentation and patient rights.

The Constitutional Court considered the obligations of medical organisations concerning the maintenance and storage of medical documentation.

The case concerned the legal requirements governing medical records and patients' ability to access documentation reflecting their health status.

The Court examined provisions of Article 79 of Federal Law No. 323-FZ.

Legal principle

Medical organisations have statutory duties to maintain and preserve medical documentation.

Medical documentation is not merely an internal administrative record. It is also an important instrument for protecting patient rights.

Relevance to clinical algorithms

When AI-assisted medical recommendations influence clinical treatment, preserving relevant records can be essential for determining:

What information was available to the doctor.

What recommendation the algorithm generated.

Whether the doctor reviewed that recommendation.

Whether the recommendation was followed or rejected.

Whether an error contributed to patient injury.

The judgment provides a useful foundation for arguments concerning the preservation of algorithm-assisted clinical records, although it does not expressly establish an AI logging requirement.

Consultant Plus

8. Civil liability for opaque or incorrect clinical algorithms

Clinical algorithm transparency is closely connected with medical negligence and compensation for injury.

Three principal actors may be involved.

Responsible partyPotential legal responsibility
Medical professionalFailure to exercise appropriate clinical judgment or verify an unsafe recommendation.
Medical organisationDefective implementation, inadequate supervision or failure to maintain safe medical systems.
Software developer/manufacturerDefective software, inadequate validation, misleading instructions or failure to address known safety risks.

A. Article 1064 of the Russian Civil Code

This provision establishes the general principle of compensation for harm caused to another person.

A patient may seek compensation where legally relevant elements of civil liability are established.

B. Article 1068 – Liability for employees

An organisation may be liable for harm caused by its employee while performing employment duties.

This may become relevant where a hospital employee improperly uses an AI-based clinical system.

C. Article 1095 – Harm caused by defects in goods, work or services

This provision is particularly relevant when defective products or services cause injury.

Depending on the legal relationship and circumstances, a defective medical software product or related service may raise questions under this provision.

D. Article 1096 – Persons liable for harm caused by defects

This provision identifies persons who may be responsible for harm caused by defects in goods, work or services.

E. Article 1098 – Grounds for exemption

The law recognises circumstances in which a person responsible under the defective-product liability framework may be exempted.

The application of these provisions depends on the facts, the nature of the software and the relevant contractual and statutory relationships.

Illustration

Suppose a hospital uses AI software to detect brain tumours.

The algorithm incorrectly classifies a tumour as harmless. The doctor accepts the recommendation without appropriate clinical assessment, resulting in delayed treatment.

A subsequent investigation may examine:

Whether the software was properly validated.

Whether the manufacturer provided adequate safety information.

Whether the hospital used the software for its approved purpose.

Whether the doctor acted with appropriate professional care.

Whether the algorithmic error caused or contributed to the injury.

The existence of an algorithm does not automatically establish the liability of any one participant. Causation, fault where required, product defects and other applicable legal requirements must be examined.

9. Criminal liability for clinical algorithm failures

Russian criminal law may become relevant where an algorithm-assisted medical error results in serious injury or death.

Important provisions include:

Article 109 of the Criminal Code: Causing death by negligence.

Article 118: Causing serious harm to health by negligence.

Article 293: Negligence by an official, where the statutory requirements are satisfied.

Article 238: Provision of services that do not meet safety requirements, where its specific elements are established.

For example, if a doctor knowingly ignores serious clinical warning signs because an algorithm has provided a reassuring prediction, criminal liability may be investigated if the applicable statutory elements are established.

Similarly, a developer's responsibility may be examined where culpable conduct in designing, releasing or maintaining unsafe medical software contributed to a patient's injury.

Importantly, artificial intelligence itself is not a criminally responsible legal person under Russian criminal law.

A 2026 Russian legal study specifically examines the division of criminal responsibility between doctors and developers in AI-assisted diagnosis, emphasising causation, professional negligence and preservation of digital evidence.

RCSI Journals Platform

 

10. Transparency obligations of hospitals and AI developers

Although Russia does not yet provide a comprehensive clinical algorithm transparency statute, the existing legislation supports several important compliance practices.

Transparency requirementPractical application
Disclosure of AI involvementInform patients where algorithmic involvement is material to understanding their treatment.
Clinical validationMaintain evidence supporting the system's intended medical performance.
Human oversightEnsure appropriate medical professionals evaluate clinically significant recommendations.
Record preservationPreserve relevant algorithmic outputs and medical decisions.
Data protectionProtect patient information from unlawful access or disclosure.
Risk disclosureExplain material treatment risks and relevant limitations.
Error reportingEstablish procedures for identifying and addressing unsafe algorithmic outputs.
AccountabilityIdentify the responsibilities of hospitals, doctors and developers.

These are practical compliance recommendations derived from the existing legal framework, not a claim that every item is already a separate express statutory obligation.

11. Legal challenges in Russia

There are several unresolved problems in the Russian regulatory framework.

1. Absence of a specific right to algorithmic explanation

Russian legislation provides rights to medical information and certain explanations of automated decisions, but does not establish a general right to understand every clinical algorithm's internal logic.

2. Black-box diagnostic systems

Some AI systems produce predictions without providing doctors or patients with understandable explanations.

This creates difficulties in identifying the reasons for an incorrect diagnosis.

3. Unclear division of responsibility

It may be difficult to determine whether an injury resulted from defective software, poor medical supervision, inadequate hospital procedures or a combination of these factors.

4. Patient consent

Existing informed-consent requirements do not expressly establish a universal obligation to disclose every use of clinical AI.

5. Algorithmic discrimination

Algorithms trained using unrepresentative medical datasets may produce less accurate results for particular patient groups.

Russia lacks a comprehensive, dedicated statutory system of clinical AI fairness audits.

6. Evidence preservation

If hospitals do not preserve algorithm versions, input data and outputs, establishing the cause of a medical error can become difficult.

7. Commercial confidentiality

Manufacturers may seek to protect their software architecture and proprietary algorithms. However, commercial confidentiality should not be confused with a right to withhold medical information that patients are legally entitled to receive.

r.law-books.ru+2

12. Proposed reforms for clinical algorithm transparency

Russia could strengthen patient protection through a dedicated clinical AI transparency framework.

The following reforms would be particularly useful:

1. Mandatory AI-use disclosure: Require healthcare organisations to inform patients when AI materially influences important diagnostic or treatment decisions.

2. Right to meaningful explanation: Establish a right to receive an understandable explanation of significant algorithm-assisted clinical recommendations.

3. Mandatory human review: Require appropriate medical professionals to review high-risk clinical decisions.

4. Algorithmic audit requirements: Introduce independent clinical performance, safety and bias assessments.

5. Digital audit trails: Require preservation of algorithm versions, clinical inputs, outputs and subsequent human decisions.

6. Clear liability rules: Define the responsibilities of medical professionals, healthcare organisations, software developers and manufacturers.

7. Patient objection mechanisms: Establish effective procedures for challenging significant automated clinical decisions.

8. Special protection for vulnerable patients: Introduce stronger safeguards for children, elderly patients and patients unable to provide informed consent.

9. Clinical incident reporting: Create procedures for reporting serious AI-related medical errors.

10. Regulatory supervision: Strengthen oversight by relevant healthcare and personal-data supervisory authorities.

These reforms would help establish a more accountable system in which technological innovation does not undermine patient autonomy.

13. Comparative legal perspective

Russia's regulatory approach can be understood more clearly by comparing it with international standards.

Legal systemApproach to clinical algorithm transparency
RussiaGeneral patient rights, personal-data protections and sectoral medical regulation.
European UnionGDPR automated-decision safeguards and AI Act requirements for high-risk AI systems.
United StatesFDA oversight of relevant medical-device software and healthcare privacy regulation.
United KingdomMedical-device regulation, data protection and clinical safety governance.

The EU framework is particularly relevant because it provides more developed rules for automated decision-making and high-risk AI systems.

However, these foreign laws do not automatically apply to Russian healthcare organisations.

14. Important legal principles

The following principles summarise the legal position:

Patient autonomy: Medical decisions must respect the patient's legally protected autonomy.

Informed consent: Medical intervention must comply with statutory informed-consent requirements.

Medical confidentiality: Clinical algorithms must operate within applicable confidentiality requirements.

Data protection: Patient health information must be processed lawfully.

Human responsibility: AI assistance does not automatically remove the professional responsibilities of doctors.

Accountability: Medical organisations and developers may face liability when their legally relevant conduct contributes to injury.

Transparency: Patients have statutory rights to medical information and certain explanations of automated decisions, but no general statutory entitlement to inspect every algorithm.

15. Conclusion

Clinical Algorithm Transparency Law in Russia is an emerging area of healthcare regulation that combines constitutional rights, medical legislation, personal-data protection, medical-device regulation and civil liability.

Federal Law No. 323-FZ provides the foundation for informed consent, patient information and medical confidentiality. Federal Law No. 152-FZ provides important protections against certain exclusively automated decisions through Article 16.

The Constitutional Court's Judgment No. 1-P of 13 January 2020 and Judgment No. 31-P of 13 July 2022 provide useful judicial foundations concerning medical information and documentation. The European Court of Human Rights judgment in Konovalova v. Russia also illustrates the importance of patient autonomy and privacy.

Nevertheless, the central regulatory weakness remains the absence of a comprehensive statutory right to meaningful explanations of clinical AI systems.

Ultimately, Russian healthcare law must balance technological innovation with patient autonomy, medical safety, confidentiality and accountability. Clinical algorithms should support professional medical judgment rather than become unaccountable substitutes for it.

16. Important legislation and case-law reference list

AuthorityRelevance
Constitution of Russia, Articles 21, 23, 24, 29 and 41Fundamental rights and health protection
Federal Law No. 323-FZ (2011), Articles 19, 20, 22, 73 and 79Patients' rights and medical responsibilities
Federal Law No. 152-FZ (2006), Articles 5, 9, 10 and 16Personal-data protection and automated decisions
Federal Law No. 258-FZ (2020)Experimental legal regimes
Government Resolution No. 1416 (2012)Medical-device registration
Russian Civil Code, Articles 1064, 1068, 1095 and 1096Civil liability
Russian Criminal Code, Articles 109, 118, 238 and 293Potential criminal liability
Constitutional Court Judgment No. 1-P (2020)Medical-documentation access
Constitutional Court Judgment No. 31-P (2022)Medical-documentation obligations
Konovalova v. Russia (2014)Medical privacy and patient autonomy

17. Research sources

Russian Ministry of Health – Federal Law No. 323-FZ.

Federal Law No. 152-FZ – Personal Data.

Article 16 – Automated Decision-Making.

Federal Law No. 258-FZ – Experimental Legal Regimes.

Constitutional Court Judgment No. 1-P of 2020.

Constitutional Court Judgment No. 31-P of 2022.

Konovalova v. Russia – ECtHR Judgment.

Russian legal research on criminal liability for AI-assisted diagnosis.

Academic note: This is a research-oriented explanation of the legal framework, not an assertion that Russia has enacted a standalone Clinical Algorithm Transparency Act. The precise application of individual provisions depends on the type of algorithm, the medical decision and the circumstances of its use.

LawGratis provides pro bono legal aid and resources to empower communities. Join us in making justice reachable for everyone! Follow our community on Instagram, YouTube, Facebook, and LinkedIn.

LEAVE A COMMENT